Cargando…
mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs
Platinum resistance is a major cause of treatment failure and mortality in epithelial ovarian cancer. mTORC1/2 inhibitors, which impair mRNA translation, can re-sensitize resistant ovarian cancer cells to platinum chemotherapy but the mechanism remains poorly described. Using platinum-resistant OVCA...
Autores principales: | David-West, Gizelka, Ernlund, Amanda, Gadi, Abhilash, Schneider, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145695/ https://www.ncbi.nlm.nih.gov/pubmed/30237852 http://dx.doi.org/10.18632/oncotarget.25869 |
Ejemplares similares
-
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development
por: Liu, Pin, et al.
Publicado: (2017) -
Reassessment of the Role of TSC, mTORC1 and MicroRNAs in Amino Acids-Meditated Translational Control of TOP mRNAs
por: Patursky-Polischuk, Ilona, et al.
Publicado: (2014) -
LARP1 functions as a molecular switch for mTORC1-mediated translation of an essential class of mRNAs
por: Hong, Sungki, et al.
Publicado: (2017) -
PI3K/Akt promotes feedforward mTORC2 activation through IKKα
por: Dan, Han C., et al.
Publicado: (2016) -
Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras
por: Sung, Suhyun, et al.
Publicado: (2015)